Codi QR

Efficacy and safety of intravenous OPC‐61815 compared with oral tolvaptan in patients with congestive heart failure

Abstract Aims This multicentre, randomized, controlled, double‐blind, parallel‐group Phase III study was conducted to confirm the non‐inferiority of OPC‐61815 (tolvaptan sodium phosphate) intravenous injections to oral tolvaptan tablets in patients with congestive heart failure and volume overload d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Naoki Sato, Shingo Uno, Yuka Kurita, Seongryul Kim, the OPTION‐HF Investigators
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2022-10-01
Col·lecció:ESC Heart Failure
Matèries:
Accés en línia:https://doi.org/10.1002/ehf2.14021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!